CELL INTELLIGENCE · 肿瘤细胞治疗研究

解读宫颈癌年龄特异性分子特征并构建血管-免疫预后模型

Deciphering age-specific molecular features in cervical cancer and constructing an angio-immune prognostic model.

晚期实体瘤患者中 monalizumab 联合 durvalumab 的 I/II 期研究

Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors.

尽管疗效有限，monalizumab 联合 durvalumab 耐受性良好，且在外周血和 TME 中观察到了令人鼓舞的免疫激活。